On September 12, BRT Apartments, Inc. announced that it would be paying a quarterly dividend of $0.18 per share to its stockholders and that it would be renewing its stock repurchase program. BRT is a real estate investment trust that has not paid a dividend since September 2009. The company may buy back up to […]
On September 12, Aldeyra Therapeutics reported positive results from its clinical trial of a treatment for dry eye disease. The company plans to continue its phase 2 clinical trials in early 2018. The news triggered a Sonal level 2 alert at 7:00 am before the stock price rose from $4. The stock price surged over […]
On September 20, Alnylam Pharmaceuticals (ALNY) reported exciting stage 3 clinical trial results. Its drug, patisiran, treats a rare nerve disorder called familial amyloid polyneuropathy. Alnylam will seek regulatory approval for patisiran later this year. Sonal sent out a level 2 alert at 7 am, and the next trade was at $93.50. The price rose […]
After the close of the markets on September 21, AECOM (ACM) unveiled a new capital allocation policy and stock repurchase program. AECOM is a global infrastructure firm that plans to spend all available free cash flow to pay down debt until reaching a target level sometime in 2018. This plan includes a stock repurchase program […]
On September 20, Quad Graphics reported that it landed a $450 million printing contract. The Minnesota-based company will print all catalogs for the online retailer and fellow Minnesotans, Bluestem Brands, Inc. The news triggered a level 3 Sonal alert at 4:05 pm. The next trade occurred at 4:13 pm in after-hours trading for $20.1645. […]
Lannett Company (LCI) announced on September 27 that is had received FDA approval for a new drug. The Oxycodone and Acetaminophin tablets USP, 5 mg/325 mg and 10 mg/325 mg are the therapeutic equivalent to the drug Percocet. U.S. sales of Oxycodone and Acetaminophin tablets USP, 5 mg/325 mg and 10 mg/325 mg totaled around […]
On September 20, Phoenix Color Corp, a wholly owned subsidiary of ALJ Regional Holdings, entered into an asset purchase agreement with LSC Communications and Moore-Langen Printing. In the agreement, ALJ will obtain printing and manufacturing facilities in Terre Haute, Indiana. Sonal sent a level 3 alert to its subscribers at 7:01 am on September […]
Sage Therapeutics announced disappointing results on its late-stage clinical trial of a brexanolone treament for a seizure disorder called super-refractory status epilepticus (SRSE). Right now there is no U.S. drug approved for the condition. Sonal caught the news at 6:15 am with a level 2 alert before the stock price fell from $88.22 to $74.65. […]
On September 20, Halcon Resources (HK) announced plans to divest its remaining non-operated oil assets in the Williston Basin to an undisclosed company for $104 million. Halcon started selling assets in the Williston Basin earlier this year in order to pay down its debt and focus on its operations in the Delaware Basin. Sonal […]
Alnylam Pharmaceuticals reported exciting stage 3 clinical trial results on September 20. Its drug, patisiran, treats a rare nerve disorder called familial amyloid polyneuropathy. Alnylam will seek regulatory approval for patisiran later this year. Sonal sent out a level 2 alert at 7 am, and the next trade was at $93.50 during pre-market trading. […]
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.